Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis - Summary - MDSpire
Advertisement
Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis
To assess the causal effects of circulating metabolites, gut microbiota traits, and immune cell phenotypes on the risk of deep infiltrating endometriosis (DIE), emphasizing the significance of understanding the gut-immune-pelvic axis.
Key Findings:
Causal associations identified between circulating metabolites, gut microbiota, and immune phenotypes with DIE susceptibility.
324 protein-coding genes were identified, with 42 differentially expressed between DIE and controls, highlighting potential molecular targets.
A five-gene panel (HDC, GADD45B, CDK5, AHNAK, RASGRP2) showed high discrimination between DIE lesions and normal endometrium (AUC = 0.999), indicating its diagnostic potential.
Immunohistochemistry confirmed upregulation of HDC, GADD45B, AHNAK, RASGRP2 and downregulation of CDK5 in DIE lesions, supporting the relevance of these genes.
Interpretation:
The findings support a gut-immune-pelvic pathway in DIE, highlighting the role of metabolic, microbial, and immune factors in its pathogenesis and suggesting avenues for future research.
Limitations:
The study primarily relies on genetic proxies, which may not capture all relevant environmental factors, potentially limiting the scope of findings.
The generalizability of findings may be limited to specific populations represented in the GWAS data, necessitating further validation in diverse cohorts.
Conclusion:
This study provides evidence for a biologically plausible five-gene signature associated with DIE, suggesting potential targets for therapeutic intervention and further exploration in clinical settings.